Free Trial

Anpario (LON:ANP) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?

Anpario logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Anpario dipped below its 200‑day moving average
  • Analyst sentiment is positive with an average rating of Buy and a consensus price target of GBX 570; Canaccord upgraded to Buy and raised its target from GBX 457 to GBX 570.
  • Key fundamentals: market capitalization £87.1 million, P/E ratio 13.55, debt‑to‑equity 0.60, and strong liquidity (current ratio 4.50, quick ratio 5.16).
  • Five stocks we like better than Anpario.

Anpario plc (LON:ANP - Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 495.14 and traded as low as GBX 490. Anpario shares last traded at GBX 514, with a volume of 16,855 shares changing hands.

Analysts Set New Price Targets

ANP has been the topic of a number of recent analyst reports. Shore Capital Group reiterated a "house stock" rating on shares of Anpario in a research report on Monday, January 19th. Canaccord Genuity Group upgraded Anpario to a "buy" rating and increased their price objective for the stock from GBX 457 to GBX 570 in a research report on Thursday, April 2nd. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of GBX 570.

Get Our Latest Report on ANP

Anpario Stock Up 1.8%

The stock has a 50 day moving average price of GBX 496.17 and a 200-day moving average price of GBX 495.14. The stock has a market capitalization of £87.10 million, a P/E ratio of 13.55 and a beta of 0.92. The company has a debt-to-equity ratio of 0.60, a current ratio of 4.50 and a quick ratio of 5.16.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines